FR940602-2-00108 FR940602-2-00069 Manufacturer of Controlled Substances; Application Pursuant to section 1301.43(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on April 15, 1994, Radian Corporation, 8501 Mopac Blvd., P.O. Box 201088, Austin, Texas 78720, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ␣ 1␣ 1Schedule Drug: Cathinone (1235) I Methcathinone (1237) I Aminorex (1585) I 4-Methylaminorex (cis isomer) (1590) I Methaqualone (2565) I Ibogaine (7260) I Lysergic acid diethylamide (7315) I Tetrahyrocannabinols (7370) I Mescaline (7381) I 3,4-Methylenedioxyamphetamine (7400) I 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxy meth amphetamine (7405) I 4-Methoxyamphetamine (7411) I Heroin (9200) I Normorphine (9313) I Acetylmethadol (9601) I 3-Methylfentanyl (9813) I Amphetamine (1100) II Methamphetamine (1105) II Methylphenidate (1724) II Amobarbital (2125) II Pentobarbital (2270) II Secobarbital (2315) II Phencyclidine (7471) II Oxycodone (9143) II Hydromorphone (9150) II Benzoylecgonine (9180) II Hydrocodone (9193) II Meperidine (9230) II Methadone (9250) II Morphine (9300) II Oxymorphone (9652) II Alfentanil (9737) II Sufentanil (9740) II Fentanyl (9801) II The firm plans to manufacture deuterated material for use in exempt products. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than July 5, 1994. Dated: May 23, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;13398 Filed 6&hyph;1&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
